AI Article Synopsis

  • The study explored how the NMDA receptor antagonist MK-801 affects neuropathic pain and microglial activity in rats after nerve injury.
  • MK-801 was injected following spinal nerve ligation to see if it influenced pain responses and microglial activation.
  • Results indicated that MK-801 increased pain thresholds and reduced microglial activity, suggesting a connection between microglial activation and the persistence of neuropathic pain.

Article Abstract

The neuropathic pain that occurs after peripheral nerve injury may be related to abnormal central activity. The present experiments investigated the effects of MK-801 [N-methyl-D-aspartate (NMDA) receptor antagonist] on neuropathic pain behaviors and microglial activity in rats. Neuropathic pain was produced by L5 spinal nerve ligation of rats. MK-801 was injected to determine whether spinal microglial activation after nerve injury plays a crucial role in the development and/or maintenance of neuropathy through the NMDA receptor. Mechanical allodynia of the hind paw was examined with von Frey filaments postoperatively. Microglial activity was measured by observing changes in immunoreactivity with a microglia marker, OX-42. The MK-801, at a dose of 3 or 30 µg/5 µl, injection group showed higher neuropathic pain threshold and reduction of microglial activity. These results suggest that neuropathic pain behaviors following L5 spinal nerve ligation may be related to altered activity of the microglia involving the NMDA receptor, and chronological changes of microglial activation by MK-801 are related to maintenance of mechanical allodynia.

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNR.0b013e328362e7dfDOI Listing

Publication Analysis

Top Keywords

neuropathic pain
20
mechanical allodynia
12
nmda receptor
12
microglial activity
12
chronological changes
8
nerve injury
8
pain behaviors
8
spinal nerve
8
nerve ligation
8
microglial activation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!